Discovery of 4-Piperazine Isoquinoline Derivatives as Potent and Brain-Permeable Tau Prion Inhibitors with CDK8 Activity

Published on Jan 30, 2020in ACS Medicinal Chemistry Letters4.345
· DOI :10.1021/ACSMEDCHEMLETT.9B00480
Jean-Marc M. Grandjean2
Estimated H-index: 2
(UCSF: University of California, San Francisco),
Alexander Y. Jiu2
Estimated H-index: 2
(UCSF: University of California, San Francisco)
+ 17 AuthorsNick A. Paras10
Estimated H-index: 10
(UCSF: University of California, San Francisco)
Sources
Abstract
Tau prions feature in the brains of patients suffering from Alzheimer’s disease and other tauopathies. For the development of therapeutics that target the replication of tau prions, a high-content, fluorescence-based cell assay was developed. Using this high-content phenotypic screen for nascent tau prion formation, a 4-piperazine isoquinoline compound (1) was identified as a hit with an EC50 value of 390 nM and 0.04 Kp,uu. Analogs were synthesized using a hypothesis-based approach to improve potency and in vivo brain penetration resulting in compound 25 (EC50 = 15 nM; Kp,uu = 0.63). We investigated the mechanism of action of this series and found that a small set of active compounds were also CDK8 inhibitors.
📖 Papers frequently viewed together
References14
Newest
#1Atsushi Aoyagi (Daiichi Sankyo)H-Index: 6
#2Carlo Condello (UCSF: University of California, San Francisco)H-Index: 16
Last. Stanley B. Prusiner (UCSF: University of California, San Francisco)H-Index: 189
view all 17 authors...
The hallmarks of Alzheimer’s disease (AD) are the accumulation of Aβ plaques and neurofibrillary tangles composed of hyperphosphorylated tau. We developed sensitive cellular assays using human embryonic kidney–293T cells to quantify intracellular self-propagating conformers of Aβ in brain samples from patients with AD or other neurodegenerative diseases. Postmortem brain tissue from patients with AD had measurable amounts of pathological Aβ conformers. Individuals over 80 years of age had the lo...
Source
#1Xi Meiyang (Shaoxing University)H-Index: 11
#2Tingkai Chen (CPU: China Pharmaceutical University)H-Index: 7
Last. Haopeng Sun (CPU: China Pharmaceutical University)H-Index: 26
view all 11 authors...
Abstract Cyclin-dependent kinases 8 (CDK8) regulates transcriptional process via associating with the mediator complex or phosphorylating transcription factors (TF). Overexpression of CDK8 has been observed in various cancers. It mediates aberrant activation of Wnt/β-catenin signaling pathway, which is initially recognized and best studied in colorectal cancer (CRC). CDK8 acts as an oncogene and represents a potential target for developing novel CDK8 inhibitors in cancer therapeutics. However, o...
Source
#1Jacob I. Ayers (UF: University of Florida)H-Index: 18
#2Benoit I. Giasson (UF: University of Florida)H-Index: 84
Last. David R. Borchelt (UF: University of Florida)H-Index: 92
view all 3 authors...
Abstract Tau is a microtubule-associated protein that functions in regulating cytoskeleton dynamics, especially in neurons. Misfolded and aggregated forms of tau produce pathological structures in a number of neurodegenerative diseases, including Alzheimer’s disease (AD) and tauopathy dementias. These disorders can present with a sporadic etiology, such as in AD, or a familial etiology, such as in some cases of frontotemporal dementia with parkinsonism. Notably, the pathological features of tau ...
Source
#1Dominic J PascoeH-Index: 3
#2Kenneth Ling (Syngenta)H-Index: 8
Last. Scott L. CockroftH-Index: 27
view all 3 authors...
Favorable molecular interactions between group 16 elements have been implicated in catalysis, biological processes, and materials and medicinal chemistry. Such interactions have since become known as chalcogen bonds by analogy to hydrogen and halogen bonds. Although the prevalence and applications of chalcogen-bonding interactions continues to develop, debate still surrounds the energetic significance and physicochemical origins of this class of σ-hole interaction. Here, synthetic molecular bala...
Source
#1Amanda L. Woerman (UCSF: University of California, San Francisco)H-Index: 12
#2Atsushi Aoyagi (UCSF: University of California, San Francisco)H-Index: 6
Last. Stanley B. Prusiner (UCSF: University of California, San Francisco)H-Index: 189
view all 10 authors...
Tau prions are thought to aggregate in the central nervous system, resulting in neurodegeneration. Among the tauopathies, Alzheimer’s disease (AD) is the most common, whereas argyrophilic grain disease (AGD), corticobasal degeneration (CBD), chronic traumatic encephalopathy (CTE), Pick’s disease (PiD), and progressive supranuclear palsy (PSP) are less prevalent. Brain extracts from deceased individuals with PiD, a neurodegenerative disorder characterized by three-repeat (3R) tau prions, were use...
Source
#1Paul Czodrowski (Merck KGaA)H-Index: 22
#2Aurélie Mallinger (ICR: Institute of Cancer Research)H-Index: 8
Last. Kai SchiemannH-Index: 10
view all 18 authors...
The mediator complex-associated cyclin dependent kinase CDK8 regulates β-catenin-dependent transcription following activation of WNT signaling. Multiple lines of evidence suggest CDK8 may act as an oncogene in the development of colorectal cancer. Here we describe the successful optimization of an imidazo-thiadiazole series of CDK8 inhibitors that was identified in a high-throughput screening campaign and further progressed by structure-based design. In several optimization cycles, we improved t...
Source
#1Aurélie Mallinger (ICR: Institute of Cancer Research)H-Index: 8
#2Kai Schiemann (Merck KGaA)H-Index: 10
Last. Julian BlaggH-Index: 40
view all 22 authors...
We demonstrate a designed scaffold-hop approach to the discovery of 2,8-disubstituted-1,6-naphthyridine- and 4,6-disubstituted-isoquinoline-based dual CDK8/19 ligands. Optimized compounds in both series exhibited rapid aldehyde oxidase-mediated metabolism, which could be abrogated by introduction of an amino substituent at C5 of the 1,6-naphthyridine scaffold or at C1 of the isoquinoline scaffold. Compounds 51 and 59 were progressed to in vivo pharmacokinetic studies, and 51 also demonstrated su...
Source
#1Travis T. Wager (Pfizer)H-Index: 26
#2Xinjun Hou (Pfizer)H-Index: 23
Last. Anabella Villalobos (Pfizer)H-Index: 13
view all 4 authors...
Significant progress has been made in prospectively designing molecules using the central nervous system multiparameter optimization (CNS MPO) desirability tool, as evidenced by the analysis reported herein of a second wave of drug candidates that originated after the development and implementation of this tool. This simple-to-use design algorithm has expanded design space for CNS candidates and has further demonstrated the advantages of utilizing a flexible, multiparameter approach in drug disc...
Source
#1Michel Goedert (LMB: Laboratory of Molecular Biology)H-Index: 37
BACKGROUND Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the most common human neurodegenerative diseases. AD is primarily a dementing disease, and PD is a movement disorder. Together, they affect around 50 million people worldwide, with the vast majority of disease cases being sporadic. Their incidence increases with age. Like most neurodegenerative diseases, AD and PD are caused by the aggregation of a small number of proteins, with filament assemblies constituting the end-point of...
Source
The human brain is a uniquely complex organ, which has evolved a sophisticated protection system to prevent injury from external insults and toxins. Designing molecules that can overcome this protection system and achieve optimal concentration at the desired therapeutic target in the brain is a specific and major challenge for medicinal chemists working in CNS drug discovery. Analogous to the now widely accepted rule of 5 in the design of oral drugs, the physicochemical properties required for o...
Source
Cited By3
Newest
#1David J. Ingham (KU: University of Kansas)H-Index: 2
#2Bryce R Blankenfeld (KU: University of Kansas)H-Index: 1
Last. Truman Christopher Gamblin (UTSA: University of Texas at San Antonio)H-Index: 1
view all 6 authors...
The microtubule-associated protein tau promotes the stabilization of the axonal cytoskeleton in neurons. In several neurodegenerative diseases, such as Alzheimer's disease, tau has been found to dissociate from microtubules, leading to the formation of pathological aggregates that display an amyloid fibril-like structure. Recent structural studies have shown that the tau filaments isolated from different neurodegenerative disorders have structurally distinct fibril cores that are specific to the...
Source
#2Zhaoyan Zhang (Anhui Medical University)H-Index: 1
Last. Xin-Hua Liu (Anhui Medical University)H-Index: 18
view all 5 authors...
Cyclin-dependent kinase 8 (CDK8) plays an momentous role in transcription regulation by forming kinase module or transcription factor phosphorylation. A large number of evidences have identified CDK8 as an important factor in cancer occurrence and development. In addition, CDK8 also participates in the regulation of cancer cell stress response to radiotherapy and chemotherapy, assists tumor cell invasion, metastasis, and drug resistance. Therefore, CDK8 is regarded as a promising target for canc...
Source
#1Daniel WongH-Index: 15
#2Jay Conrad (UCSF: University of California, San Francisco)H-Index: 2
Last. Michael J. Keiser (UCSF: University of California, San Francisco)H-Index: 24
view all 12 authors...
In microscopy-based drug screens, fluorescent markers carry critical information on how compounds affect different biological processes. However, practical considerations may hinder the use of certain fluorescent markers. Here, we present a deep learning method for overcoming this limitation. We accurately generated predicted fluorescent signals from other related markers, and validated this new machine learning (ML) method on two biologically distinct datasets. We used the ML method to improve ...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.